Is it safe to take Happy Mammoth (hormone harmony) and 25mg DHEA (Dehydroepiandrosterone) with Morvyn (vitamin B) drops, considering my heterozygous MTHFR (Methylenetetrahydrofolate Reductase) gene mutation and menopausal status?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Hormone Therapy and Supplements in Menopause with MTHFR Mutation

Taking Happy Mammoth hormone harmony, 25 mg DHEA, and Morvyn vitamin B drops together may pose unnecessary risks without proven benefits for your menopausal symptoms, especially with your heterozygous MTHFR mutation. Current guidelines do not support this combination, and alternative evidence-based approaches should be considered.

Hormone Replacement Considerations

DHEA Supplementation

  • 25mg of DHEA daily is a relatively high dose and may cause androgenic side effects such as acne 1
  • DHEA supplementation has limited evidence for effectiveness in postmenopausal women and is associated with androgenic side effects (OR 3.77,95% CI 1.36 to 10.4) 1
  • While DHEA may slightly improve sexual function compared to placebo (SMD 0.31,95% CI 0.07 to 0.55), it does not improve overall quality of life 1
  • The FDA has not approved bioidentical hormone therapies like those in Happy Mammoth for prevention of chronic conditions in postmenopausal women 2

MTHFR Mutation Considerations

  • Heterozygous MTHFR mutation affects folate metabolism, which interacts with hormone therapy
  • Hormone replacement therapy can reduce plasma homocysteine levels independently of MTHFR polymorphism status 3
  • Lower plasma folate levels combined with MTHFR mutations can increase homocysteine levels, potentially increasing cardiovascular risk 4
  • Vitamin B supplementation may be beneficial for those with MTHFR mutations, but should be properly formulated for your specific needs

Evidence-Based Recommendations

For Menopausal Symptom Management

  • If hormone therapy is needed, guidelines recommend FDA-approved formulations with:
    • 17β-estradiol (preferred estrogen component)
    • Micronized progesterone (if you have an intact uterus) 5
    • Starting dose of transdermal estradiol 0.05-0.1 mg/day patch 5

For MTHFR Mutation Management

  • Vitamin B supplementation may be beneficial, but should include properly metabolized forms of folate
  • Monitor homocysteine levels, as they can be elevated with MTHFR mutations and affect cardiovascular risk

Safety Concerns

  • Combination of unregulated hormone products (Happy Mammoth) with DHEA may lead to unpredictable hormone levels
  • Contraindications for hormone therapy include:
    • Active liver disease
    • History of breast cancer
    • Coronary heart disease
    • Previous venous thromboembolism or stroke 5
  • Hormone therapy risks include:
    • Increased breast cancer risk (especially with combined estrogen-progestin therapy)
    • Stroke
    • Venous thromboembolism (RR 2.14, highest in first year of use) 5
    • Gallbladder disease (1.8-fold higher for current HRT users) 5

Alternative Approaches

  • Non-hormonal options for managing menopausal symptoms include:
    • Venlafaxine, desvenlafaxine, paroxetine, citalopram, or escitalopram 5
    • Cognitive behavioral therapy and hypnosis 5
    • Regular weight-bearing exercise
    • Maintaining healthy weight
    • Smoking cessation 5
    • Vaginal moisturizers and lubricants for vaginal symptoms 5

If you choose to pursue hormone therapy, consult with a healthcare provider who can prescribe FDA-approved formulations with proper monitoring, rather than continuing with unregulated supplements that may have unpredictable effects, especially considering your MTHFR mutation status.

References

Research

Dehydroepiandrosterone for women in the peri- or postmenopausal phase.

The Cochrane database of systematic reviews, 2015

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Hormone Replacement Therapy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.